Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
2
TGA:2
Drug Approvals
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial (391176)
- Product Name
- TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
- Approval Date
- May 30, 2024
TGA
BRUKINSA zanubrutinib 80 mg capsule bottle (338475)
- Product Name
- BRUKINSA zanubrutinib 80 mg capsule bottle
- Approval Date
- Oct 7, 2021
TGA
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)No trials found
News
No news found